Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

LIEBEL-FLARSHEIM

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 31
  • 0 comments

FDA approve IOVERSOL

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 31
  • 0 comments

FDA approve ABACAVIR SULFATE

Comment Full text

TOLMAR

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 30
  • 0 comments

FDA approve METRONIDAZOLE

Comment Full text

GLENMARK GENERICS

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 33
  • 0 comments

FDA approve URSODIOL

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 36
  • 0 comments

FDA approve TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

AM REGENT

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 30
  • 0 comments

FDA approve LEVOCARNITINE

Comment Full text

SANDOZ

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 29
  • 0 comments

FDA approve METAXALONE

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 31
  • 0 comments

FDA approve IODIXANOL

Comment Full text

GE HEALTHCARE

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 33
  • 0 comments

FDA approve IODIXANOL

Comment Full text

LIEBEL-FLARSHEIM

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 33
  • 0 comments

FDA approve IOVERSOL

Comment Full text
  • Previous
  • 831
  • 832
  • 833
  • 834
  • 835
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5692)
  • SEC News(255655)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152081)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin